Cargando…
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment
Background. Prader-Willi syndrome (PWS) is a rare neurodevelopmental disorder causing quality of life impairments such as insatiable hunger (hyperphagia) and obesity. We explored caregivers’ willingness to assume treatment risk in exchange for reduced hyperphagia according to a PWS-validated observe...
Autores principales: | Tsai, Jui-Hua, Crossnohere, Norah L., Strong, Theresa, Bridges, John F. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419554/ https://www.ncbi.nlm.nih.gov/pubmed/34497876 http://dx.doi.org/10.1177/23814683211039457 |
Ejemplares similares
-
High levels of caregiver burden in Prader-Willi syndrome
por: Kayadjanian, Nathalie, et al.
Publicado: (2018) -
Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry
por: Bohonowych, Jessica E., et al.
Publicado: (2021) -
Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015) -
The High Direct Medical Costs of Prader-Willi Syndrome
por: Shoffstall, Andrew J., et al.
Publicado: (2016) -
The Global Prader–Willi Syndrome Registry: Development, Launch, and Early Demographics
por: Bohonowych, Jessica, et al.
Publicado: (2019)